Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

familial primary hypomagnesemia News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study identifies pathogenic variants of the GATA3 gene as the cause of hypomagnesemia in patients with hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome. This discovery enhances understanding of the genetic underpinnings of these rare conditions.

A recent study explores the link between early-onset calcium pyrophosphate disease and genetic hypomagnesemia, expanding the understanding beyond Gitelman syndrome. This research highlights the genetic factors contributing to these conditions.

A recent study shows that dapagliflozin effectively corrects hypomagnesemia in kidney transplant patients. This finding could influence treatment protocols for managing magnesium levels post-transplant.

Not rare diseases news,news about your rare disease.

Earlier

A recent study identifies pathogenic variants of the GATA3 gene as the cause of hypomagnesemia in patients with hypoparathyroidism, sensorineural deafness, and renal dysplasia syndrome. This discovery enhances understanding of the genetic underpinnings of these rare conditions.

A recent study explores the link between early-onset calcium pyrophosphate disease and genetic hypomagnesemia, expanding the understanding beyond Gitelman syndrome. This research highlights the genetic factors contributing to these conditions.

A recent study shows that dapagliflozin effectively corrects hypomagnesemia in kidney transplant patients. This finding could influence treatment protocols for managing magnesium levels post-transplant.

Not rare diseases news,
news about your rare disease.